The frequencies of MYC, BCL2, and BCL6 rearrangement and concurrent MYC/BCL2 rearrangements are similar to those reported in DLBCL in earlier studies [10, 11, 31–34]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.